Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma.

Autor: Stauffer, Stacey1 (AUTHOR), Roth, Jacob S.2 (AUTHOR) jacob.roth@einsteinmed.edu, Hernandez, Edjay R.3 (AUTHOR), Kowalczyk, Joshua T.3 (AUTHOR), Sealover, Nancy E.4 (AUTHOR) robert.kortum@usuhs.edu, Hebron, Katie E.1 (AUTHOR), James, Amy5 (AUTHOR), Isanogle, Kristine A.5 (AUTHOR), Riffle, Lisa A.6 (AUTHOR), Ileva, Lilia6 (AUTHOR), Luo, Xiaoling7 (AUTHOR), Chen, Jin-Qiu7 (AUTHOR), Kedei, Noemi7 (AUTHOR), Kortum, Robert L.4 (AUTHOR), Lei, Haiyan3 (AUTHOR), Shern, Jack F.3 (AUTHOR), Kalen, Joseph D.6 (AUTHOR), Edmondson, Elijah F.8 (AUTHOR), Hall, Matthew D.2 (AUTHOR), Difilippantonio, Simone5 (AUTHOR)
Zdroj: Cancers. Jul2024, Vol. 16 Issue 13, p2320. 18p.
Databáze: Academic Search Ultimate